UC Davis, UCSF receive major gifts in support of medicine, research and modernization
The University of California, San Francisco (UCSF) received a $100 million gift from Kathy Chiao and Kenneth Hao to fund hospital modernization, innovation initiatives, and cancer research. The donation includes $50 million for capital projects like a new UCSF Health Helen Diller Hospital and a 104-bed expansion at UCSF Benioff Children’s Hospital Oakland, including a 20-bed behavioral health unit.
The University of California, San Francisco (UCSF) has secured a $100 million commitment from longtime supporters Kathy Chiao and Kenneth Hao. The funds will address critical capital needs, accelerate innovation in healthcare, and advance cancer research through the Weill Cancer Hub West, a collaboration with Stanford University. The donation is split between $50 million for capital projects, $40 million for innovation initiatives, and $10 million for the Weill Cancer Hub West. Key projects include the modernization of UCSF’s century-old Parnassus Heights campus, featuring a new state-of-the-art UCSF Health Helen Diller Hospital, and a new hospital building at UCSF Benioff Children’s Hospital Oakland. The Oakland expansion will add 104 inpatient beds, including a 20-bed inpatient behavioral health unit. Chiao and Hao have been longstanding supporters of UCSF, with Hao currently serving as vice chair of the UCSF Board of Directors and co-chair of the UCSF Health Executive Council. Their investment aligns with UCSF’s mission to drive innovation in science, healthcare, and higher education. The donation follows a $75 million gift from the couple to UC Davis’ Weill School of Veterinary Medicine, announced in April. That funding supports a new small-animal hospital, veterinary student scholarships, and research connecting animal and human medicine. The couple has also supported UC Berkeley’s School of Public Health through scholarships and programs like Impact Innovators, which fosters community health initiatives. Additionally, the couple provided $5 million last year to UCSF for the Impact Monitoring Platform for AI in Clinical Care (IMPACC). This platform assesses the safety and efficacy of AI tools in healthcare, helping leaders determine if they achieve intended results or pose risks like worsening health disparities. The funds will also accelerate translational medicine research, bridging discoveries between UC Davis and UCSF for broader health impacts.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.